|
|
 |
|
| Overview |
IFN-α stands for interferon alpha. Mouse IFN-α is a recombinant protein optimized for use in cell culture, differentiation studies, and functional assays.
Mouse IFN-α can be used for studies of in vitro and in vivo effects of IFN-α in mouse models, e.g., for the in vitro investigation of antitumor effects (antiproliferative capacities) of IFN-α on tumor cell lines or for stimulation of IFN-α-dependent cell lines. In vivo, recombinant mouse IFN-α can be utilized in studies using transgenic mice harboring the Cre-recombinase transgene driven by the interferon-inducible Mx promoter (Mx-Cre mice)3. |
| Details |
Background information Type I interferons (IFNs), including IFN-α, are a family of cytokines that exert multiple functions in the immune system1,2. The most prominent effect of IFN-α is its antiviral activity. Upon viral infections, host cells release IFN-α which can act in an autocrine or paracrine manner to activate intracellular antiviral defense mechanisms and restrict viral replication. Furthermore, IFN-α affects the generation and function of various dendritic cell populations. Immunomodulatory activity and antitumor effects have been described both in vivo and in vitro. The recombinant Mouse IFN-α was expressed in HEK293 cells and has been purified and analyzed for its activity (107 U/mL). Quality description Research-grade cytokines are suitable for a wide variety of cell culture applications. They are sterile-filtered prior to lyophilization. Generally, endotoxin levels are <0.1 ng/µg (<1 EU/µg), and purities are >95%. The biological activity is tested in appropriate bioassays. |
| |
| Figure 1 |
| Mouse IFN-α activity assay. The biological activity of Mouse IFN-α was determined by inhibition assay using a T lymphoma cell line (BW cells). |
 |
|
|
|
 |
| Favorites / Prices |
Request prices or add products to your favorite list.
|
| Details |
|
| References |
| 1. Pestka et al. (2004) Immunol. Rev. 202: 8–32. |
| 2. Takaoka et al. (2006) Cell. Microbiol. 8: 907–922. |
| 3. Kühn et al. (1995) Science 269: 1427–1429. |
|
|
|
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
|